{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T14:13:35Z","timestamp":1770560015477,"version":"3.49.0"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1097\/gme.0b013e31818af10a","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T19:48:58Z","timestamp":1242935338000},"page":"293-300","source":"Crossref","is-referenced-by-count":29,"title":["Tamoxifen use and endometrial lesions"],"prefix":"10.1097","volume":"16","author":[{"given":"Raquel P.","family":"Dibi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio G.","family":"Zettler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzana A.","family":"Pessini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice V.","family":"Ayub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzane B.","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo P.G.","family":"da Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210227","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/jcp.55.7.514","article-title":"The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium.","volume":"55","author":"Mourits","year":"2002","journal-title":"J Clin Pathol"},{"key":"R3-13-20210227","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(89)91141-0","article-title":"Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers.","volume":"1","author":"Fornander","year":"1989","journal-title":"Lancet"},{"key":"R5-13-20210227","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(00)02677-5","article-title":"Risk and prognosis of endometrial cancer after tamoxifen for breast cancer.","volume":"356","author":"Bergman","year":"2000","journal-title":"Lancet"},{"key":"R6-13-20210227","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/jcp.52.4.278","article-title":"Endometrial pathologies in postmenopausal tamoxifen treatment: comparison between gynaecological symptomatic and gynaecological asymptomatic breast cancer patients.","volume":"52","author":"Cohen","year":"1999","journal-title":"J Clin Pathol"},{"key":"R7-13-20210227","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0020-7292(99)00079-X","article-title":"Hysteroscopic evaluation of the endometrium of post-menopausal patients with breast cancer before and after tamoxifen use.","volume":"66","author":"Goncalves","year":"1999","journal-title":"Int J Gynaecol Obstet"},{"key":"R8-13-20210227","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1067\/mob.2001.108332","article-title":"Role of hysteroscopy in detection and extraction of endometrial polyps: results of a prospective study.","volume":"184","author":"Gebauer","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R9-13-20210227","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1053\/beog.2000.0183","article-title":"Ultrasound, hysteroscopy and endometrial biopsy in the investigation of endometrial cancer.","volume":"15","author":"Symonds","year":"2001","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R10-13-20210227","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/A:1014957524845","article-title":"Hysteroscopic assessment of menopausal breast-cancer patients taking tamoxifen; there is a bias from the mode of endometrial sampling in estimating endometrial morbidity?","volume":"72","author":"Garuti","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"R11-13-20210227","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2559.2002.01343.x","article-title":"Ki-67 protein: the immaculate deception?","volume":"40","author":"Brown","year":"2002","journal-title":"Histopathology"},{"key":"R12-13-20210227","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/excr.2000.4888","article-title":"The Ki-67 protein: fascinating forms and an unknown function.","volume":"257","author":"Endl","year":"2000","journal-title":"Exp Cell Res"},{"key":"R14-13-20210227","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/gyno.2000.5859","article-title":"Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.","volume":"78","author":"Deligdisch","year":"2000","journal-title":"Gynecol Oncol"},{"key":"R15-13-20210227","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/gyno.1994.1029","article-title":"Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic postmenopausal breast cancer patients.","volume":"52","author":"Cohen","year":"1994","journal-title":"Gynecol Oncol"},{"key":"R16-13-20210227","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1200\/JCO.1999.17.7.2050","article-title":"Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening.","volume":"17","author":"Love","year":"1999","journal-title":"J Clin Oncol"},{"key":"R17-13-20210227","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0378-5122(96)01043-2","article-title":"Transvaginal ultrasonography and endometrial changes in postmenopausal breast cancer patients receiving tamoxifen.","volume":"25","author":"Dijkhuizen","year":"1996","journal-title":"Maturitas"},{"key":"R18-13-20210227","doi-asserted-by":"crossref","first-page":"275","DOI":"10.7863\/jum.1993.12.5.275","article-title":"Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen.","volume":"12","author":"Cohen","year":"1993","journal-title":"J Ultrasound Med"},{"key":"R19-13-20210227","first-page":"604","article-title":"The effect of tamoxifen on the endometrium, serum lipids and hypothalamus pituitary axis in the postmenopausal breast cancer patients.","volume":"79","author":"Kavak","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R20-13-20210227","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1148\/radiology.200.1.8657895","article-title":"MR imaging appearance of the uterus in postmenopausal women receiving tamoxifen therapy for breast cancer: histopathologic correlation.","volume":"200","author":"Ascher","year":"1996","journal-title":"Radiology"},{"key":"R21-13-20210227","first-page":"86","article-title":"The effects of tamoxifen therapy on the endometrium.","volume":"21","author":"Zarbo","year":"2000","journal-title":"Eur J Gynaecol Oncol"},{"key":"R22-13-20210227","first-page":"15451","article-title":"Tamoxifen for early breast cancer: an overview of the randomized trials.","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"R24-13-20210227","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ygyno.2004.03.048","article-title":"Endometrial pathologies associated with postmenopausal tamoxifen treatment.","volume":"94","author":"Cohen","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R25-13-20210227","first-page":"660","article-title":"Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen.","volume":"81","author":"Lahti","year":"1993","journal-title":"Obstet Gynecol"},{"key":"R26-13-20210227","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(89)91741-8","article-title":"Tamoxifen and the uterus and endometrium.","volume":"2","author":"Neven","year":"1989","journal-title":"Lancet"},{"key":"R27-13-20210227","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000291821","article-title":"Different coexisting endometrial histological features in asymptomatic postmenopausal breast cancer patients treated with tamoxifen.","volume":"43","author":"Cohen","year":"1997","journal-title":"Gynecol Obstet Invest"},{"key":"R28-13-20210227","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/gyno.1997.4739","article-title":"Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.","volume":"66","author":"Cheng","year":"1997","journal-title":"Gynecol Oncol"},{"key":"R29-13-20210227","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1046\/j.1524-4741.2001.20038.x","article-title":"Endometrial lesions after tamoxifen therapy in breast cancer women.","volume":"7","author":"Maugeri","year":"2001","journal-title":"Breast J"},{"key":"R30-13-20210227","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0002-9378(98)70315-1","article-title":"Abnormalities detected on transvaginal ultrasonography in tamoxifen treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.","volume":"178","author":"McGonigle","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"R31-13-20210227","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0090-8258(03)00276-2","article-title":"Recurrent endometrial polyps in postmenopausal breast cancer patients on tamoxifen.","volume":"90","author":"Biron-Shental","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R32-13-20210227","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ctrv.2003.09.004","article-title":"The effects of tamoxifen on the female genital tract.","volume":"30","author":"Senkus-Konefka","year":"2004","journal-title":"Cancer Treat Rev"},{"key":"R33-13-20210227","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1002\/cncr.10587","article-title":"The significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women.","volume":"94","author":"Cohen","year":"2000","journal-title":"Cancer"},{"key":"R34-13-20210227","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00004347-198906000-00005","article-title":"Endometrial polyps in PM patients receiving tamoxifen.","volume":"8","author":"Nuovo","year":"1989","journal-title":"Int J Gynecol Pathol"},{"key":"R35-13-20210227","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1200\/JCO.2000.18.20.3464","article-title":"Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.","volume":"18","author":"Gerber","year":"2000","journal-title":"J Clin Oncol"},{"key":"R36-13-20210227","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(05)78091-0","article-title":"Longitudinal hysteroscopic follow-up during tamoxifen treatment.","volume":"351","author":"Neven","year":"1998","journal-title":"Lancet"},{"key":"R37-13-20210227","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00004347-199910000-00003","article-title":"Endometrial cancer in postmenopausal breast cancer patients with tamoxifen treatment.","volume":"18","author":"Cohen","year":"1999","journal-title":"Int J Gynecol Pathol"},{"key":"R38-13-20210227","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1074-3804(00)80038-9","article-title":"Hysteroscopic evaluation of the endometrium in postmenopausal women taking tamoxifen.","volume":"7","author":"Ceci","year":"2000","journal-title":"J Am Assoc Gynecol Laparosc"},{"key":"R39-13-20210227","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0002-9378(99)70210-3","article-title":"Endometrial cancer in polyps associated with tamoxifen use.","volume":"180","author":"Ramondetta","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R40-13-20210227","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/gyno.1999.5558","article-title":"Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients.","volume":"75","author":"Cohen","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R41-13-20210227","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1006\/gyno.1996.4568","article-title":"Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients.","volume":"64","author":"Tepper","year":"1997","journal-title":"Gynecol Oncol"},{"key":"R42-13-20210227","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0029-7844(97)00591-7","article-title":"Uterine side effects of tamoxifen: a need for systemic pretreatment screening.","volume":"191","author":"Berliere","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R43-13-20210227","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1471-0528.2003.02098.x","article-title":"The differential expression of estrogen receptors, progesterone receptors, Bcl-2 and Ki-67 in endometrial polyps.","volume":"110","author":"Taylor","year":"2003","journal-title":"BJOG"},{"key":"R44-13-20210227","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.maturitas.2005.11.007","article-title":"Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen.","volume":"54","author":"McGurgan","year":"2006","journal-title":"Maturitas"},{"key":"R45-13-20210227","first-page":"667","article-title":"Histopathologic findings in thickened endometria, as measured by ultrasound, in asymptomatic postmenopausal breast cancer patients on various adjuvant treatment including tamoxifen.","volume":"18","author":"Willen","year":"1998","journal-title":"Anticancer Res"},{"key":"R46-13-20210227","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0090-8258(91)90330-8","article-title":"Oncogenic potential of tamoxifen on endometrium of postmenopausal women with breast cancer: a preliminary report.","volume":"42","author":"Gal","year":"1991","journal-title":"Gynecol Oncol"},{"key":"R47-13-20210227","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1525-1438.2006.00525.x","article-title":"Uterine effects of tamoxifen: a prospective study.","volume":"16","author":"McGonigle","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"R48-13-20210227","first-page":"674","article-title":"Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen.","volume":"39","author":"Borenstein","year":"1994","journal-title":"J Reprod Med"},{"key":"R49-13-20210227","first-page":"35","article-title":"Endometrial pathology at dilatation and curettage in breast cancer patients: comparison of tamoxifen users and non-users.","volume":"2","author":"Gibson","year":"1996","journal-title":"Cancer J"},{"key":"R50-13-20210227","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2214\/ajr.168.3.9057510","article-title":"Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.","volume":"168","author":"Hann","year":"1997","journal-title":"Am J Roentgenol"},{"key":"R51-13-20210227","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1074-3804(05)80224-5","article-title":"Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen.","volume":"4","author":"Marconi","year":"1997","journal-title":"J Am Assoc Gynecol Laparosc"},{"key":"R52-13-20210227","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/(SICI)1097-0215(19980504)76:3<325::AID-IJC7>3.0.CO;2-X","article-title":"Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study.","volume":"76","author":"Mignotte","year":"1998","journal-title":"Int J Cancer"},{"key":"R53-13-20210227","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/jnci\/85.22.1850","article-title":"Descriptive clinicopathologic study of 17 patients with endometrial cancer during or after adjuvant tamoxifen in early breast cancer.","volume":"85","author":"Fornander","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"R54-13-20210227","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jnci\/86.7.527","article-title":"Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.","volume":"86","author":"Fisher","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"R55-13-20210227","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/02841869209088912","article-title":"Carcinogenic effects of adjuvant tamoxifen treatment and radiotherapy for early breast cancer.","volume":"31","author":"Anderson","year":"1992","journal-title":"Acta Oncol"},{"key":"R56-13-20210227","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S0140-6736(94)92692-1","article-title":"Risk of endometrial cancer after tamoxifen treatment of breast.","volume":"343","author":"Van Leeuwen","year":"1994","journal-title":"Lancet"},{"key":"R57-13-20210227","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1023\/A:1018404110180","article-title":"Risk for endometrial cancer following breast cancer: a prospective study in Sweden.","volume":"8","author":"Adami","year":"1997","journal-title":"Cancer Causes Control"},{"key":"R58-13-20210227","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(05)71564-6","article-title":"Tamoxifen and risk of endometrial cancer.","volume":"357","author":"Van Leeuwen","year":"2001","journal-title":"Lancet"},{"key":"R59-13-20210227","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/jnci\/87.18.1359","article-title":"Population-based study of tamoxifen therapy and subsequent ovarian, endometrial and breast cancer.","volume":"87","author":"Cook","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"R60-13-20210227","first-page":"623","article-title":"Uterine pathologies in patients undergoing tamoxifen therapy for breast cancer: ultrasonographic, hysteroscopic and histological findings.","volume":"26","author":"Le Donne","year":"2005","journal-title":"Eur J Gynaecol Oncol"},{"key":"R61-13-20210227","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(00)02677-5","article-title":"Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of liver and endometrial cancer risk following tamoxifen.","volume":"356","author":"Bergman","year":"2000","journal-title":"Lancet"},{"key":"R62-13-20210227","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s004040050276","article-title":"The endometrium in breast cancer patients on tamoxifen.","volume":"263","author":"Dallenbach-Hellweg","year":"2000","journal-title":"Arch Gynecol Obstet"},{"key":"R63-13-20210227","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.1993.11.3.485","article-title":"High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.","volume":"11","author":"Magriples","year":"1993","journal-title":"J Clin Oncol"},{"key":"R64-13-20210227","first-page":"1475","article-title":"Tamoxifen and endometrial cancer, number 336, June 2006. American College of Obstetricians and Gynecologists.","volume":"107","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R65-13-20210227","first-page":"258","article-title":"Effects of tamoxifen on the human female genital tract: review of the literature.","volume":"24","author":"Varras","year":"2003","journal-title":"Eur J Gynaecol Oncol"},{"key":"R66-13-20210227","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/jcp.52.4.278","article-title":"Endometrial pathology in postmenopausal tamoxifen treatment: comparison between gynaecological symptomatic and asymptomatic breast cancer patients.","volume":"52","author":"Cohen","year":"1999","journal-title":"J Clin Pathol"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00042192-200916020-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:31:10Z","timestamp":1618277470000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-200916020-00013"}},"subtitle":["hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer"],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e31818af10a","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}